NCT06677086 - HIFEM for Musculoskeletal System Improvement | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 8, 2024

Primary Completion Date

January 22, 2025

Study Completion Date

January 22, 2025

Conditions

Muscle DisorderMusculoskeletal Diseases

Interventions

DEVICE

Treatment with BTL-899

The treatment administration phase will consist of four (4) treatments, delivered 5-10 days apart. The applicators of BTL-899 device will be applied over the designated area. Each treatment session will last 30 minutes.

Trial Locations (3)

11215

New York Orthopedic Hand Surgery, Brooklyn

77024

Southeast Texas Orthopedic Group, Houston

07624

Trokhan Orthopaedics LLC, Closter

All Listed Sponsors

lead

BTL Industries Ltd.

INDUSTRY